Clinical Trial Update: PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores [Phase 2, Phase 3]

View source ↗

Summary

This update covers an ongoing Phase 2/Phase 3 study evaluating PSMA-PET imaging to detect early metastatic prostate cancer in men with high Decipher test scores…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• PSMA-PET imaging tracer

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Prostate Cancer, Recurrent Prostate Cancer | Phase 2, Phase 3 | Status: RECRUITING